L Béïque

Public Health Agency of Canada — Canada

Medicine · Health Sciences

10h-index1.2kcitations36works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(8), HIV/AIDS Research and Interventions(3), Hepatitis C virus research(3), Gallbladder and Bile Duct Disorders(3), Antibiotic Use and Resistance(3)

Publications36 total

An innovative tool to prioritize the assessment of investigational COVID-19 therapeutics: A pilot project
Canada Communicable Disease Report·2024Open Access
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018
Antimicrobial Resistance and Infection Control·2023· 10 citedOpen Access
Duration of Antibiotic Therapy in Sepsis Secondary to Urinary Stones: A Retrospective Observational Study
The Canadian Journal of Hospital Pharmacy·2019· 2 citedOpen Access
Evaluating Antimicrobial Use and Spectrum of Activity in Ontario Hospitals: Feasibility of a Multicentered Point Prevalence Study
Open Forum Infectious Diseases·2018· 16 citedOpen Access
Comparison of Metronidazole q12h to q8h in Combination With Other Antibiotics on the Clinical Outcome and Readmission Rate of Patients With Appendicitis and Diverticulitis
Open Forum Infectious Diseases·2016Open Access
Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients
The Canadian Journal of Hospital Pharmacy·2015· 37 citedOpen Access
Impact of a Pathway for Chronic Obstructive Pulmonary Disease Exacerbations (COPDE) on Antimicrobial Prescribing and Readmissions
Open Forum Infectious Diseases·2015Open Access
CSHP Professional Practice Conference 2013: Poster Abstracts / Conférence sur la pratique professionnelle 2013 de la SCPH : Résumés des affiches
The Canadian Journal of Hospital Pharmacy·2013
Lack of Effect of Efavirenz on the Pharmacokinetics of Tipranavir-Ritonavir in Healthy Volunteers
Antimicrobial Agents and Chemotherapy·2009· 6 citedOpen Access
Development and psychometric validation of the HIV Treatment Knowledge Scale
AIDS Care·2007· 58 cited
Interactions between protease inhibitors and acid‐reducing agents: a systematic review
HIV Medicine·2007· 26 citedOpen Access
The Effect of ABCB1 Polymorphism on the Pharmacokinetics of Saquinavir Alone and in Combination with Ritonavir
Clinical Pharmacology & Therapeutics·2007· 16 cited
HIV Treatment Knowledge Scale
PsycTESTS Dataset·2007
Impact of Acid-Suppressive Therapy on Virologic Response to Atazanavir-Based Regimens in Antiretroviral-Experienced Patients: A Case Series
JAIDS Journal of Acquired Immune Deficiency Syndromes·2005· 19 cited
Evaluation of HIV Drug Interaction Web Sites
Annals of Pharmacotherapy·2003· 26 cited
Extrapyramidal Symptoms with Ritonavir/Indinavir plus Risperidone
Annals of Pharmacotherapy·2002· 5 cited
Extrapyramidal Symptoms with Ritonavir/Indinavir Plus Risperidone
Annals of Pharmacotherapy·2002· 59 cited
Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta‐analysis of epidemiological studies
Teratology·2000· 9 cited
Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies
Teratology·2000· 937 cited
Are the new selective alpha-blockers better than non-selective alpha-blockers for benign prostatic hyperplasia?
PubMed·1998· 2 cited
page 1 of 2Next →

Frequent Co-authors

Rosemary Zvonar(6), Gary Garber(4), D. William Cameron(4), Kathryn N. Suh(4), Deborah Kelly(3), Jonathan B. Angel(3), Paolo Mazzotta(2), Anne Pastuszak(2), Myla E. Moretti(2), Laura Hunnisett(2), Mark Friesen(2), Sheila Jacobson(2), Debra Chang(2), Orna Diav‐Citrin(2), David Chitayat(2), Irena Nulman(2), Thomas R. Einarson(2), Gideon Koren(2), John Kowal(2), Giorgio A. Tasca(2)